SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Bob L who wrote (6681)5/20/1999 8:39:00 PM
From: scaram(o)uche  Respond to of 9719
 
I've delivered the same message re. the chemo plus anti-CD20 trial for about a year now. Nothing has changed, IMO. Additive effects between C2B8 and chemo are no sweat, but synergistic effects are another issue. I may comment further in about two months.

Thanks again, Bob. I still plan to return to that clinical study, the manuscript that you have, to look for some key paragraphs here and there.

Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News